Sanofi-aventis has launched its rimonabant 20 mg/day [Acomplia] in the UK

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1545, 2006-01, pp. : 22-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sanofi-aventis has issued a `Dear Health Care Professional' letter outlining changes to the Ketek [telithromycin] label

Reactions Weekly, Vol. 1, Iss. 1145, 2007-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Sanofi-aventis has issued a `Dear Healthcare Professional' letter outlining changes to the Ketek [telithromycin] label

Inpharma, Vol. 1, Iss. 1581, 2007-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

The hyaluronan product `Suvenyl' [Aventis, Chugai] has been launched in Japan

Inpharma, Vol. 1, Iss. 1255, 2000-01 ,pp. : 26-26

Adis International

Access to resources Recommend Favorite

The obesity treatment rimonabant [Slimona] has been launched in India

Inpharma, Vol. 1, Iss. 1591, 2007-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Celecoxib 200 mg/day has a beneficial anti-inflammatory effect in patients with AS

Inpharma, Vol. 1, Iss. 1278, 2001-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite